カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の光線性角化症治療市場2023-2030：治療法別（外用、手術、光線力学的療法）、薬剤クラス別、エンドユーザー別、地域別

【英語タイトル】Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV024）・商品コード：GRV23NOV024
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：170
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：治療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

光線性角化症治療市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の光線性角化症治療市場規模は2023年から2030年にかけて年平均成長率4.3%を記録し、2030年までに89億米ドルに達する見込みです。同市場は、光線性角化症治療薬の幅広い入手可能性、同疾患に対する意識の高まり、AK治療の増加などの要因により、成長機会を目の当たりにすることが期待されています。さらに、光線性角化症の有病率の増加や、世界的な老人人口の増加が、予測期間中の市場成長を促進すると予想されます。

浸潤性扁平上皮がんは、AKから悪性化（iSCC）すると発症する可能性があります。iSCCの潜在的な原因はいくつかありますが、AKは最も頻度の高い原因の1つです。さらに、基底細胞がんや非黒色腫皮膚がんもAKから発生する可能性があります。その結果、販売チャネルを問わずAK製品に対する需要は、合併症の予防戦略として、光線性角化症の早期診断と治療が原動力となっています。

さらに、将来のパイプライン医薬品と併用療法の増加が、市場の主要な促進要因となっています。例えば、Almirall, S.A.は、研究開発第III相段階にあるKlisyri（適応拡大）を有しています。さらに、革新的な医薬品の受け入れと商業化の増加も、市場成長を促進すると予測される要因のひとつです。さらに、研究開発活動の活発化により、光線性角化症の治療に使用される新規薬剤の承認が加速されると予想されるため、予測期間中の成長が促進されます。

主要企業は、世界中で市場シェアを拡大するために、製品の発売、提携、拡大戦略などの戦略的イニシアチブを採用しています。例えば、2022年6月、BIOFRONTERA AGは、スイスに拠点を置くLouis Widmer SAが、Ameluzによる体幹、四肢、頸部の光線性角化症の管理に関する販売承認の延長を受けたと発表しました。さらに、2020年7月、BIOFRONTERA AGは、ノルウェー、フィンランド、ノルウェー、アイスランドにおけるBF-RhodoLEDおよびAmeluzの販売に関する契約をGalenica ABと締結したと発表しました。

光線性角化症治療市場レポートハイライト

- 2022年の売上高シェアは手術が65.6%で最大でした。これは光線性角化症の治療における凍結療法手術の採用が増加しているためです。

- ヌクレオシド代謝阻害剤は2022年に32.4%の最大売上シェアを占め、予測期間中もその優位性を維持する見込みです。

- アジア太平洋地域は、AKの有病率の高さ、医療インフラの急速な発展、アジア太平洋諸国による医療費の増加などの要因により、予測期間中にCAGR 5.6%で最速の成長が見込まれます。

- 北米は、光線性角化症に対する人々の意識の高まり、強固な治療オプションの利用可能性、医療インフラの改善などにより、2022年に41.5%の最大の収益シェアを獲得し、市場を支配しました。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の光線性角化症治療市場変数・傾向・範囲
第4章 世界の光線性角化症治療市場：治療法別予測・傾向分析
第5章 世界の光線性角化症治療市場：薬剤クラス別予測・傾向分析
第6章 世界の光線性角化症治療市場：エンドユーザー別予測・傾向分析
第7章 世界の光線性角化症治療市場：地域別予測・傾向分析
第8章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Therapy
1.1.2. Drug class
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Therapy outlook
2.2.2. Drug class outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Actinic Keratosis Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Actinic Keratosis Treatment Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Actinic Keratosis Treatment Market: Therapy Estimates & Trend Analysis
4.1. Actinic Keratosis Treatment Market: Key Takeaways
4.2. Actinic Keratosis Treatment Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Topical
4.3.1. Topical market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Surgery
4.4.1. Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Photodynamic Therapy
4.5.1. Photodynamic therapy market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Actinic Keratosis Treatment Market: Drug Class Estimates & Trend Analysis
5.1. Actinic Keratosis Treatment Market: Key Takeaways
5.2. Actinic Keratosis Treatment Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Nucleoside Metabolic Inhibitor
5.3.1. Nucleoside metabolic inhibitor market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. NSAIDS
5.4.1. NSAIDS market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Immune Response Modifiers
5.5.1. Immune response modifiers market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Photoenhancers
5.6.1. Photoenhancers market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Actinic Keratosis Treatment Market: End-use Estimates & Trend Analysis
6.1. Actinic Keratosis Treatment Market: Key Takeaways
6.2. Actinic Keratosis Treatment Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Private Clinics Delivery
6.4.1. Private clinics delivery market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Homecare
6.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Actinic Keratosis Treatment Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Actinic Keratosis Treatment Market by Region: Key Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Almirall S.A.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. LEO Pharma A/S
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Sun Pharmaceutical Industries Ltd.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Novartis AG
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. GALDERMA
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Ortho Dermatologics (Bausch Health Companies Inc.)
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. BIOFRONTERA AG
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Hill Dermaceuticals, Inc.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives 

List of Tables

1. List of Abbreviations
2. North America actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
3. North America actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
4. North America actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
5. North America actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
6. U.S. actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
7. U.S. actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
8. U.S. actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
9. Canada actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
10. Canada actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
11. Canada actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
12. Europe actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
13. Europe actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
14. Europe actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
15. Europe actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
16. Germany actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
17. Germany actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
18. Germany actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
19. UK actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
20. UK actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
21. UK actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
22. France actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
23. France actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
24. France actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
25. Italy actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
26. Italy actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
27. Italy actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
28. Spain actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
29. Spain actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
30. Spain actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
31. Sweden actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
32. Sweden actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
33. Sweden actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
34. Norway actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
35. Norway actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
36. Norway actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
37. Denmark actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
38. Denmark actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
39. Denmark actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
40. Asia Pacific actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
41. Asia Pacific actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
42. Asia Pacific actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
43. Asia Pacific actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
44. China actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
45. China actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
46. China actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
47. Japan actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
48. Japan actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
49. Japan actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
50. India actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
51. India actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
52. India actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
53. Thailand actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
54. Thailand actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
55. Thailand actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
56. South Korea actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
57. South Korea actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
58. South Korea actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
59. Latin America actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
60. Latin America actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
61. Latin America actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
62. Latin America actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
63. Brazil actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
64. Brazil actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
65. Brazil actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
66. Mexico actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
67. Mexico actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
68. Mexico actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
69. Argentina actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
70. Argentina actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
71. Argentina actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
72. Middle East and Africa actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
73. Middle East and Africa actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
74. Middle East and Africa actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
75. Middle East and Africa actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
76. South Africa actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
77. South Africa actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
78. South Africa actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
79. Saudi Arabia actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
80. Saudi Arabia actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
81. Saudi Arabia actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
82. UAE actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
83. UAE actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
84. UAE actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
85. Kuwait actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
86. Kuwait actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
87. Kuwait actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)

List of Figures

1. Market research process
2. Data triangulation techniques
3. Primary research pattern
4. Market research approaches
5. Value-chain-based sizing & forecasting
6. QFD modeling for market share assessment
7. Market formulation & validation
8. Actinic keratosis treatment: Market outlook
9. Actinic keratosis treatment: Competitive insights
10. Parent market outlook
11. Related/ancillary market outlook
12. Penetration and growth prospect mapping
13. Industry value chain analysis
14. Actinic keratosis treatment market driver impact
15. Actinic keratosis treatment market restraint impact
16. Actinic keratosis treatment market strategic initiatives analysis
17. Actinic keratosis treatment market: Therapy movement analysis
18. Actinic keratosis treatment market: Therapy outlook and key takeaways
19. Topical market estimates and forecasts, 2018 - 2030 (USD Million)
20. Surgery market estimates and forecasts, 2018 - 2030 (USD Million)
21. Photodynamic therapy market estimates and forecasts, 2018 - 2030 (USD Million)
22. Actinic keratosis treatment market: Drug class movement analysis
23. Actinic keratosis treatment market: Drug class outlook and key takeaways
24. Nucleoside metabolic inhibitor market estimates and forecasts, 2018 - 2030 (USD Million)
25. NSAIDS market estimates and forecasts, 2018 - 2030 (USD Million)
26. Immune response modifiers market estimates and forecasts, 2018 - 2030 (USD Million)
27. Photoenhancers market estimates and forecasts, 2018 - 2030 (USD Million)
28. Others market estimates and forecasts, 2018 - 2030 (USD Million)
29. Actinic keratosis treatment market: End-use movement analysis
30. Actinic keratosis treatment market: End-use outlook and key takeaways
31. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
32. Private clinics delivery market estimates and forecasts, 2018 - 2030 (USD Million)
33. Homecare market estimates and forecasts, 2018 - 2030 (USD Million)
34. Others market estimates and forecasts, 2018 - 2030 (USD Million)
35. Global actinic keratosis treatment market: Regional movement analysis
36. Global actinic keratosis treatment market: Regional outlook and key takeaways
37. North America market estimates and forecasts, 2018 - 2030 (USD Million)
38. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
39. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
40. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
41. UK market estimates and forecasts, 2018 - 2030 (USD Million)
42. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
43. France market estimates and forecasts, 2018 - 2030 (USD Million)
44. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
45. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
46. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
47. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
48. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
49. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
50. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
51. China market estimates and forecasts, 2018 - 2030 (USD Million)
52. India market estimates and forecasts, 2018 - 2030 (USD Million)
53. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
54. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
55. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
56. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
57. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
58. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
59. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
60. Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
61. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
62. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
63. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
64. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

★調査レポート[世界の光線性角化症治療市場2023-2030：治療法別（外用、手術、光線力学的療法）、薬剤クラス別、エンドユーザー別、地域別] (コード：GRV23NOV024)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の光線性角化症治療市場2023-2030：治療法別（外用、手術、光線力学的療法）、薬剤クラス別、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の多形膠芽腫治療市場2023-2030：治療別（放射線療法、免疫療法）、薬剤クラス別、エンドユーザー別、地域別
  • 世界の慢性腎臓病治療市場2023-2030：治療法別（薬剤、透析）、エンドユーザー別（病院、透析センター、その他）、地域別
  • 世界の卵巣がん治療薬市場（2023-2030）：治療クラス別（PARP、PD-L1、血管新生阻害剤）、治療法別、最終用途別、地域別
  • 世界の大腸がん治療薬市場2023-2030：薬剤クラス別（化学療法、免疫療法）、地域別（北米、アジア太平洋、中南米、ヨーロッパ）
  • 世界のゴーシェ病治療薬市場2023-2030：種類別（1型、2型、3型、その他）、治療法別（酵素補充療法、基質補充療法、その他）、地域別
  • 世界の吸入可能医薬品市場2023-2030：薬剤クラス別（エアゾール、ドライパウダー製剤、スプレー）、用途別（呼吸器疾患、非呼吸器疾患）、地域別
  • 世界の喘息治療薬市場2023-2030：薬剤クラス別（抗炎症薬、併用療法）、製品別（吸入器、ネブライザー）、投与経路別、地域別
  • 世界の軟部腫瘍市場2023-2030：治療法別（標的療法、化学療法、血管新生阻害薬、放射線療法）、投与経路別（経口、非経口、その他）、エンドユーザー別（病院、在宅医療、専門センター、その他）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆